MS-Selfie Research

Updates on ground-breaking MS research that may have an impact on how you manage your MS in the future. This will include conference highlights and important MS-related events.

The European Association of Neurology (EAN) meeting is my first face-2-face conference since March 2020.
13
18
Why is natalizumab not licensed to treat progressive MS? Listen now (13 min) | New data shows that natalizumab has an impact on chronic active lesions, including slowly expanding lesions, and indicates that…
18
65
#EBVcausesMSWatch now (22 min) | My thoughts on what needs to be done to prove that EBV causes MS. We need to start the research programme sooner than later.
22
57
I am going to be an optimist and give this new class of treatment a 75% chance of success (range 60-90%), mainly due to their anti-B-cell effects, and a…
12
33
Time matters: should British people with MS accept sup-optimal care?Listen now (11 min) | In the #AttackMS trial we are comparing starting natalizumab within 2 weeks of symptom onset to those starting natalizumab after 2…
16
25
What is my neurofilament level doing?Listen now (14 min) | The FDA has granted the plasma NFL assay Breakthrough Device designation as a prognostic aid in assessing patients with…
13
6
It is not good enough to simply target stabilisation or slowing down of disability worsening. I want to participate in a trial that offers an…
13
40
See all